Training for Ophthalmic Use of Strontium-90
(1)Is an authorized user under OAR 333-116-0690 (Training for Therapeutic Use of Brachytherapy Source) or equivalent Nuclear Regulatory Commission or Agreement State requirements; or
(2)Has completed 24 hours of classroom and laboratory training applicable to the medical use of strontium-90 for ophthalmic radiotherapy.
(a)The training must include:
(A)Radiation physics and instrumentation;
(C)Mathematics pertaining to the use and measurement of radioactivity; and
(D)Radiation biology; and
(b)Supervised clinical training in ophthalmic radiotherapy under the supervision of an authorized user at a medical institution that includes the use of strontium-90 for the ophthalmic treatment of five individuals. This supervised clinical training must involve:
(A)Examination of each individual to be treated;
(B)Calculation of the dose to be administered;
(C)Administration of the dose;
(D)Follow up and review of each individual’s case history; and
(E)Has obtained written attestation, signed by a preceptor authorized user who meets the requirements in OAR 333-116-0740 (Training for Experienced Authorized User, Radiation Safety Officer, Teletherapy or Medical Physicist, Authorized Medical Physicist, Nuclear Pharmacist or Authorized Nuclear Pharmacist), 333-116-0690 (Training for Therapeutic Use of Brachytherapy Source), 333-116-0700 (Training for Ophthalmic Use of Strontium-90), or equivalent Nuclear Regulatory Commission or Agreement State requirements, that the individual has satisfactorily completed the requirements in section (2) of this rule and has achieved a level of competency sufficient to function independently as an authorized user of strontium-90 for ophthalmic use.
Rule 333-116-0700 — Training for Ophthalmic Use of Strontium-90,